Lipella pharmaceuticals to present at propthink digital investor conference

Chief medical officer dr. michael chancellor will discuss hemorrhagic cystitis and the company's lead candidate, lp-10 pittsburgh, pa, february 20, 2023 – lipella pharmaceuticals inc. (nasdaq: lipo) (“lipella,” “our,” “us” or the “company”) a pioneering, clinical-stage pharmaceutical company, announced today that chief medical officer dr.
LIPO Ratings Summary
LIPO Quant Ranking